Eileen Brett

Eileen Brett's Title

Eileen Brett is currently serving as the Vice President of Program Leadership. In this capacity, she brings over 25 years of experience in the biotechnology sector, where she has specialized in cell and gene therapy. Her role involves leading large cross-functional teams, ensuring the successful execution of complex projects, and building robust team leadership and portfolio processes.

Eileen Brett's Education and Expertise

Eileen Brett holds an MBA from The Wharton School, University of Pennsylvania, one of the world's leading business schools. She also earned a BS in Mechanical Engineering from Villanova University. Her technical background in mechanical engineering, combined with advanced business acumen, enables her to navigate and lead in the highly specialized field of biotechnology. Her expertise spans process engineering, program leadership, and strategic development across capital projects, supply chain, and R&D.

Eileen Brett's Background

Eileen Brett has had a distinguished career in biotechnology, marked by significant contributions to cell and gene therapy. She has held pivotal roles in process engineering and program leadership, where she has been instrumental in the design, build, and start-up of new biologics facilities. Her leadership in capital projects, supply chain, and R&D has driven the successful delivery of numerous high-stakes initiatives. Eileen's ability to lead large cross-functional teams and her focus on developing successful team leaders and portfolio processes have been key to her success.

Eileen Brett's Achievements

During her tenure as the Head of CMC Leadership Biotherapeutics at Janssen R&D, Eileen Brett built a high-performing team and oversaw a portfolio that experienced a remarkable 400% growth in just four years. She also chaired the CMC Governance Council, demonstrating her leadership and strategic oversight capabilities. Eileen's achievements include leading the facility and process design, build, and start-up of both pilot plants and commercial biologics facilities, showcasing her ability to manage complex projects and deliver outstanding results.